Goel Mita Sanghavi, Burns Risa B, Phillips Russell S, Davis Roger B, Ngo-Metzger Quyen, McCarthy Ellen P
Division of General Internal Medicine, Department of Medicine, Feinberg School of Medicine, Northwestern University, Chicago, IL 60611, USA.
J Gen Intern Med. 2005 Jul;20(7):604-11. doi: 10.1111/j.1525-1497.2005.0090.x.
Breast-conserving surgery (BCS) has been the recommended treatment for early-stage breast cancer since 1990 yet many women still do not receive this procedure.
To examine the relationship between birthplace and use of BCS in Asian-American and Pacific-Islander (AAPI) women, and to determine whether disparities between white and AAPI women persist over time.
Retrospective cohort study.
Women with newly diagnosed stage I or II breast cancer from 1992 to 2000 in the Surveillance, Epidemiology, and End Results program.
Receipt of breast -conserving surgery for initial treatment of stage I or II breast cancer.
Overall, AAPI women had lower rates of BCS than white women (47% vs 59%; P<.01). Foreign-born AAPI women had lower rates of BCS than U.S.-born AAPI and white women (43% vs 56% vs 59%; P<.01). After adjustment for age, marital status, tumor registry, year of diagnosis, stage at diagnosis, tumor size, histology, grade, and hormone receptor status, foreign-born AAPI women (adjusted OR [aOR], 0.49; 95% CI, 0.32 to 0.76) and U.S.-born AAPI women (aOR, 0.77; 95% CI, 0.62 to 0.95) had lower odds of receiving BCS than white women. Use of BCS increased over time for each racial/ethnic group; however, foreign-born AAPI women had persistently lower rates of BCS than non-Hispanic white women.
AAPI women, especially those who are foreign born, are less likely to receive BCS than non-Hispanic white women. Of particular concern, differences in BCS use among foreign-born and U.S.-born AAPI women and non-Hispanic white women have persisted over time. These differences may reflect inequities in the treatment of early-stage breast cancer for AAPI women, particularly those born abroad.
自1990年以来,保乳手术(BCS)一直是早期乳腺癌的推荐治疗方法,但仍有许多女性未接受该手术。
研究亚裔美国人和太平洋岛民(AAPI)女性的出生地与保乳手术使用之间的关系,并确定白人和AAPI女性之间的差异是否随时间持续存在。
回顾性队列研究。
1992年至2000年在监测、流行病学和最终结果计划中确诊为I期或II期乳腺癌的女性。
接受保乳手术作为I期或II期乳腺癌初始治疗。
总体而言,AAPI女性接受保乳手术的比例低于白人女性(47%对59%;P<0.01)。外国出生的AAPI女性接受保乳手术的比例低于美国出生的AAPI女性和白人女性(43%对56%对59%;P<0.01)。在调整年龄、婚姻状况、肿瘤登记、诊断年份、诊断阶段、肿瘤大小、组织学、分级和激素受体状态后,外国出生的AAPI女性(调整后的比值比[aOR],0.49;95%置信区间,0.32至0.76)和美国出生的AAPI女性(aOR,0.77;95%置信区间,0.62至0.95)接受保乳手术的几率低于白人女性。每个种族/族裔群体的保乳手术使用率都随时间增加;然而,外国出生的AAPI女性接受保乳手术的比例一直低于非西班牙裔白人女性。
AAPI女性,尤其是外国出生的女性,比非西班牙裔白人女性接受保乳手术的可能性更小。特别值得关注的是,外国出生和美国出生的AAPI女性与非西班牙裔白人女性在保乳手术使用上的差异一直存在。这些差异可能反映了AAPI女性,尤其是国外出生的女性在早期乳腺癌治疗中的不平等。